US Patent 11253585 Vaccine compositions having improved stability and immunogenicity
Patent 11253585 was granted and assigned to Novavax on February, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11253585 Vaccine compositions having improved stability and immunogenicity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
